Abiopharma

Clinical trial NCT04904549 updates: 1. status: COMPLETED → TERMINATED 2. start date: 2020-08-20 → 2021-05-26 3. enrollment: 23726 → 23670 participants

Clinical trial NCT07484022: start date: 2026-04-01 → 2026-06-01.

Clinical trial NCT07511387 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 40 → 50 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04164199 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-05-23 3. primary completion date: 2026-07-01 → 2026-05-23

Clinical trial NCT04338204 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-03-30 → 2025-09-30 3. primary completion date: 2026-03-30 → 2025-09-30 4. enrollment: 120 → 102 participants 5. enrollment type: ESTIMATED → ACTUAL

Dormant shares - change in the number of shares

Clinical trial NCT06052631: start date: 2026-06-07 → 2026-06-08.

Clinical trial NCT02780310 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01

Clinical trial NCT07310420: start date: 2026-05-29 → 2026-06-30.

Clinical trial NCT06585488 updates: 1. status: RECRUITING → TERMINATED 2. start date: 2024-11-26 → 2024-12-13 3. completion date: 2026-12-01 → 2026-04-23 4. primary completion date: 2026-12-01 → 2026-04-23 5. enrollment: 514 → 47 participants 6. enrollment type: ESTIMATED → ACTUAL